Special Awards
○ TOS Young Investigator Paper Award for Cancer Research
Prior Recipients
2025Recipient
Chi-An Annie Cheng, Ph.D. (程吉安)
Assistant Professor, Department of Pharmacy, National Taiwan University
Nanomedicine Advanced Diagnostics Lab 奈⽶Ｘ⽣醫Ｘ檢測實驗室
2025Recipient
Chi-An Annie Cheng, Ph.D. (程吉安)
Assistant Professor, Department of Pharmacy, National Taiwan University
Nanomedicine Advanced Diagnostics Lab 奈⽶Ｘ⽣醫Ｘ檢測實驗室
❖ RESEARCH INTERESTS
My research interests are to develop and apply next-generation nanomedicine as enabling
technologies for facilitating the advancement of diagnostics and therapeutics.
❖ EDUCATION
Ph.D. Bioengineering, UC Los Angeles (GPA: 4.00/4.00) 2015 to 2020
M.S. Bioengineering, UC Los Angeles (GPA: 4.00/4.00) 2015 to 2016
M.S. Chemistry, National Taiwan University (GPA: 4.00/4.00) 2009 to 2011
B.S. Chemistry, National Taiwan University (GPA: 3.96/4.00) 2005 to 2009
❖ WORK EXPERIENCE
Secretary General SFRR-Taiwan 2025 to present
Team Leader Drug Research Center, NTUCM 08/2024 to present
Assistant Professor (Joint) GIP-TRIAD Master’s Degree in Agro-Biomedical Science 02/2024 to present
Assistant Professor Department of Pharmacy, National Taiwan University 08/2022 to present
Post-Doc Pathology, Harvard Medical School 05/2020 to 06/2022
Post-Doc Pathology, Brigham and Women’s Hospital 05/2020 to 06/2022
Post-Doc Wyss Institute for Biologically Inspired Engineering 05/2020 to 06/2022
Research Assistant Institute of Atomic and Molecular Sciences, Academia Sinica 2014 to 2015
Patent Engineer Jianq Chyun IP Group 2013 to 2014
Research Assistant Institute of Atomic and Molecular Sciences, Academia Sinica 2009 to 2012
❖ PUBLICATIONS # equal contribution * corresponding author
Journals:
1. Hsiao, W. W.*; Lama, X. M.; Le, T. N.; Cheng, C. A.*; Chang, H. C. Exploring nanodiamonds: leveraging their
dual capacities for anticancer photothermal therapy and temperature sensing, Nanoscale 2024, 16, 14994.
2. Cheng, C. A.* Before Translating Extracellular Vesicles into Personalized Diagnostics and Therapeutics: What We Could Do, Mol. Pharmaceutics 2024, 21, 2625–2636.
• Selected as Cover Story
• Featured in Voices (Mol. Pharmaceutics 2024, 21, 7, 3082–3083) | Editorial
3. Cheng, C. A.*; Hou, K. C.; Hsu, C. W.; Chiang, L. C. Ultrasensitive and High-Resolution Protein Spatially Decoding Framework for Tumor Extracellular Vesicles, Adv.
Sci. 2024, 11, 2304926.
• Selected as Front Cover Story
• Featured in NTU Front Page/Spotlight News | NTU Pharmacy Bulletin | Quanterix
4. Cheng, C. A.*; Chiang, L. C.; Chu, Y. S. Integrated Pipeline for Ultrasensitive Protein Detection in Cancer Nanomedicine, RSC Adv. 2023, 13, 14685–14697.
5. Sherman, A. C.; Cheng, C. A.; Swank, Z.; Zhou, G.; Li, X.; Issa, N. C.; Walt, D. R.; Baden, L. R.* Soiffer, R.* Impact of Donor and Recipient SARS-CoV-2 Vaccination
or Infection on Immunity Post Hematopoietic Cell Transplantation, Transplantation and Cellular Therapy 2023, 29, 337.e1-337.e5.
6. Yonker, L.; Swank, Z.; Bartsch, Y.; Burns, M.; Kane, A.; Boribong, B.; Davis, J.; Loiselle, M.; Novak, T.; Senussi,Y.; Cheng, C. A.; Burgess, E.; Edlow, A.; J.; Chou,
Dionne, A.; Balaguru, D.; Lahoud-Rahme, M.; Arditi, M.; Julg,
B.; Randolph, A.; Alter, G.; Fasano, A.; Walt, D. R. Circulating Spike protein detected in post-COVID-19 mRNA vaccine myocarditis, Circulation 2023, 147, 867–876.
7. Duan, X.; Nie, K.*; Wang, X.; Cheng, C. A.; Zhou, R.; Hu, Z.; Yan, J.; Mei, L.; Ma, X.* Yao, S.; Wang, L.; Wang, H. Cesium manganese halide perovskite-analogue
nanocrystals with highly efficient energy conversion for flexible multifunctional fibers, Inorg. Chem. Front. 2023, 10, 1338–1347.
8. Zhou, R.; Cheng, C. A.; Wang, X.; Nie, K.*; Wu, J.; Wu, M.; Duan, X.; Hu, Z.; Ul Huq I.; Wang, H.; Wang, L.*;
Mei, L.; Liu. H.* Metal halide perovskite nanocrystals with enhanced photoluminescence and stability toward anticounterfeiting
high-performance flexible fibers, Nano Research 2023, 16, 3542–3551.
❖ Book Chapters:
1. Ogata, A. F.; Lazarovits, R.; Uwamanzu-Nna, A.; Gilboa, T.; Cheng, C. A.; Walt, D. R.* Severe Acute Respiratory
Syndrome Coronavirus 2 Antigens as Targets of Antibody Responses, Clin. Lab. Med. 2021, Vol. 42 (1) pp 97–109.
2. Kumar, N.; Chen, W.; Cheng, C. A.; Deng, T.; Wang, R.; Zink, J. I.* Stimuli-Responsive Nanomachines and Caps
for Drug Delivery. In Enzymes; Tamanoi, F.; Elesvier: Oxford, UK, 2018; Vol. 43, pp 31-65
3. Hui, Y. Y.*; Cheng, C. A.; Chen, O. Y.; Chang, H. C.* Bioimaging and Quantum Sensing Using NV Centers in
Diamond Nanoparticles. In Carbon Nanoparticles and Nanostructures; Yang, N., Jiang, X., Pang, D.W. Eds.;
Springer: Cham, Switzerland, 2016; pp 109-137.
❖ AWARDS/HONORS
2025 中華民國癌症醫學會年輕研究者癌症研究傑出論⽂獎
2024 Professor C. Y. Lee Medical Research Young Scholar Award (李鎮源教授醫學研究⻘年學者獎)
2024 Wiley Young Investigator Award
2022 Best Poster Award at the 2022 Multiomics and Precision Medicine Joint Conference
2022 Academic Research-Career Development Project (Sprout Research Project) Award—awarded by NTU(臺⼤學術研究⽣涯發展研究計畫(深耕型計畫))
2022 NTU Outstanding Scholar Award—Fubon Foundation (臺⼤富邦拔萃講座學者)
2022 NTU Awarded Incentives for Newly Employed Special Outstanding Talent (臺⼤新聘特殊優秀⼈才)
2022 Emerging Young Scholar of 2030 Cross-Generation Young Scholars Program— awarded by the National Science and Technology Council
(國科會2030跨世代年輕學者⽅案新秀學者)
2022 Yushan Young Scholar (annual support administrative expense)— awarded by the Ministry of Education(教育部⽟⼭⻘年學者⾏政⽀援費⽤補助)
2019 UCLA Dissertation Year Fellowship (UCLA畢業論⽂最⾼榮譽)
2019 North America Taiwanese Professors' Association Travel Award for Young Scholars
2019 UCLA Research Showcase Travel Award for Fall 2019 ACS National Meeting
2018 North America Taiwanese Professors' Association Travel Award for Young Scholars
2015-16 UCLA Graduate Division Fellowship Award
2012 Government Scholarship for Study Abroad— awarded by the Ministry of Education
2011 NTU Dean’s Award of College of Science— awarded to top 10% of graduates at NTU College of Science
2010 Best Poster Award at the NSF-NSC Bio-Inspired Sensing and Bio-Inspired Actuation Summer Institute
2009 NTU Dean’s Award of College of Science— awarded to top 10% of graduates at NTU College of Science
2009 Yee Fong Charitable Foundation Scholarship
2009 Honorary member of The Phi Tau Phi Scholastic Honor Society
2005-09 NTU Presidential Awards, awarded 4 semesters— awarded to top 5% of students
2008 NTU Outstanding Teaching Assistant
2008 Dalongdong Baoan Temple Scholarship
2007-08 Mr. Jin Weishi Scholarship, awarded twice
2006-09 Learning Partner from Dean's List— awarded by NTU
2025Recipient
Shih-Han Hsu (徐詩涵)
National Institute of Cancer Research
National Health Research Institutes
2025Recipient
Shih-Han Hsu (徐詩涵)
National Institute of Cancer Research
National Health Research Institutes
❖ Research Interests
Cancer therapy, cell biology, molecular pharmacology
❖ Education
2003.06~2007.06.
B.S., Life Sciences, National Yang Ming University, Taipei, Taiwan
Thesis: Construction of reporter plasmids with multiple functions for high-throughput screening of orphan G protein-coupled receptors
2007.09~2009.06
M.S., Biochemistry and Molecular Biology, National Yang Ming University, Taipei, Taiwan
Thesis: The Transcriptional Regulation and Biological Function of Coronin 1B
2012.02~2019.01
Ph.D., Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
Thesis: Investigation of the Mechanism Underlying the Ubiquitination of O6-Methylguanine-DNA Methyltransferase Induced by Alkylating Agents and Its Clinical Significance
❖ Academic and Professional Honors
2007.06 Outstanding Award at the 2007 Annual Thesis Competition(National Yang Ming University, Taipei, Taiwan)
2009.02. Master Student Scholarship(APEX BIOTECHNOLOGY CORP., Hsinchu, Taiwan)
2009.06. Outstanding Award at the 2009 Annual Thesis Competition(National Yang Ming University, Taipei, Taiwan)
2012.09. PHD Student Scholarship(National Cheng Kung University, Tainan, Taiwan)
2019.03. Dr. Tsungming Tu Thesis Award(Dr. Tsungming Tu Foundation, Taipei, Taiwan)
2019.06. The Phi Tau Phi Scholastic Honorary Membership(The Phi Tau Phi Scholastic Honor Society, Hsinchu, Taiwan)
2020.05. Lam Research Dissertation and Thesis Award(Lam Research Corporation, Fremont, CA, United States)
2022.03. Excellent Poster in 2022 NHRI Research Day(National Health Research Institutes, Miaoli, Taiwan)
2024.03. Excellent Poster in 2024 NHRI Research Day(National Health Research Institutes, Miaoli, Taiwan)
❖ Publication
1. Hsu SH, Luo CW (2007) Molecular dissection of G protein preference using Gsalpha chimeras reveals novel ligand signaling of GPCRs. Am J Physiol Endocrinol Metab 293 (4):E1021-1029.doi:10.1152/ajpendo.00003.2007. (PMID: 17652154, 2023 IF = 4.2)
2. Wang CJ, Hsu SH(co-first), Hung WT, Luo CW (2009) Establishment of a chimeric reporting system for the universal detection and high-throughput screening of G protein-coupled receptors. Biosens Bioelectron 24 (7):2298-2304. doi:10.1016/j.bios.2008.11.023. (PMID: 19135356, 2023 IF = 10.7)
3. Hsu WH, Yu YR, Hsu SH, Yu WC, Chu YH, Chen YJ, Chen CM, You LR (2013) The Wilms' tumor suppressor Wt1 regulates Coronin 1B expression in the epicardium. Exp Cell Res 319 (10):1365-1381.doi:10.1016/j.yexcr.2013.03.027. (PMID: 23562652, 2023 IF = 3.3)
4. Chang CS, Lu YJ, Chang HH, Hsu SH, Kuo PH, Shieh CC, Yao WJ, Hsu MC, Young KC, Lin WY, Huang KC, Wu CH, Tsai YS (2018) Role of adiponectin gene variants, adipokines and hydrometry-based percent body fat in metabolically healthy and abnormal obesity. Obes Res Clin Pract 12 (1S1):49-61. doi:10.1016/j.orcp.2016.05.003. (PMID: 27236826, 2023 IF = 2.5)
5. Hsu SH, Chen SH, Kuo CC, Chang JY (2018) Ubiquitin-conjugating enzyme E2 B regulates the ubiquitination of O(6)-methylguanine-DNA methyltransferase and BCNU sensitivity in human nasopharyngeal carcinoma cells. Biochem Pharmacol 158:327-338. doi:10.1016/j.bcp.2018.10.029. (PMID: 30449727, 2023 IF = 5.3)
6. Hung YH, Hsu SH, Hou YC, Chu PY, Su YY, Shan YS, Hung WC, Chen LT (2022) Semaphorin 6C Suppresses Proliferation of Pancreatic Cancer Cells via Inhibition of the AKT/GSK3/beta-Catenin/Cyclin D1 Pathway. Int J Mol Sci 23 (5). doi:10.3390/ijms23052608. (PMID: 35269749, 2023 IF = 4.9)
7. Kao WC, Hsu SH, Lin CL, Lin CY, Chen SW, Chen YX, Chen CH, Lee SW, Tsao CJ, Huang WT, Chen SH, Hsiao SY (2022) Role of high ubiquitin-conjugating enzyme E2 expression as a prognostic factor in nasopharyngeal carcinoma. Oncol Lett 23 (6):194. doi:10.3892/ol.2022.13314. (PMID: 35572494, 2023 IF = 2.5)
8. Hsu SH, Hung WC (2022) Protein arginine methyltransferase 3: A crucial regulator in metabolic reprogramming and gene expression in cancers. Cancer Lett:216008. doi:10.1016/j.canlet.2022.216008. (PMID: 36400311, 2023 IF = 9.1)
9. Hung YH, Hou YC, Hsu SH, Wang LY, Tsai YL, Shan YS, Su YY, Hung WC, Chen LT (2023) Pancreatic cancer cell-derived semaphorin 3A promotes neuron recruitment to accelerate tumor growth and dissemination. Am J Cancer Res 13 (8):3417-3432. (PMID: 37693128, 2023 IF = 3.6)
10. Hsu SH, Tsai YL, Wang YT, Shen CH, Hung YH, Chen LT, Hung WC (2024) RNF43 Inactivation Enhances the B-RAF/MEK Signaling and Creates a Combinatory Therapeutic Target in Cancer Cells. Adv Sci (Weinh):e2304820. doi:10.1002/advs.202304820. (PMID: 38225722, 2023 IF = 14.3)
11. Hung YH, Wang HC, Hsu SH, Wang LY, Tsai YL, Su YY, Hung WC, Chen LT (2024) Neuron-derived neurotensin promotes pancreatic cancer invasiveness and gemcitabine resistance via the NTSR1/Akt pathway. Am J Cancer Res 14 (2):448-466. (PMID: 38455426, 2023 IF = 3.6)
12. Hsu SH, Kuo TL, Hsu MC, Hung WC (2025) Contributions of Low‑frequency‑mutated Genes in Pancreatic Tumorigenesis and Their Implications in Precision Cancer Therapy. Journal of Cancer Research and Practice (accepted).
❖ Conference presentation
2017.03.
Poster presentation
NHRI Research Day, Miaoli, Taiwan
Topic: Inhibition of the ubiquitin-conjugating enzyme, UBE2B, restores the BCNU sensitivity of cancer cells by regulating MGMT ubiquitination
2017.09
Poster presentation
European Society of Medical Oncology Congress 2017, Madrid, Spain
Topic: Inhibition of the ubiquitin-conjugating enzyme E2B restores the BCNU sensitivity of cancer cells by regulating MGMT ubiquitination
2018.03
Poster presentation
NHRI Research Day, Miaoli, Taiwan
Topic: Inhibition of the Ubiquitin Conjugating Enzyme E2 B Restores the BCNU Sensitivity of Cancer Cells by Regulating MGMT Ubiquitination
2018.05.
Poster presentation
The 23rd Taiwan Joint Cancer Conference, Taipei, Taiwan
Topic: Ubiquitin Conjugating Enzyme E2 B Regulates the Ubiquitination of O6-Methylguanine-DNA Methyltransferase and Alkylating Chemotherapy Sensitivity in Cancer Cells
2019.03.
Poster presentation and oral presentation
The 34th Joint Annual Conference of Biomedical Science, Taipei, Taiwan
Topic: Ubiquitin-Conjugating Enzyme E2 B (UBE2B) Regulates the Sensitivity to Alkylating Agents in Human Nasopharyngeal Carcinoma Cells by Modulating the Ubiquitination of O6-Methylguanine-DNA Methyltransferase (MGMT)
2022.03.
Poster presentation
NHRI Research Day, Miaoli, Taiwan
Topic: RNF43 Inactivation Enhances the B-RAF/MEK Signaling and Creates a Combinatory Therapeutic Target in Cancer Cells
2023.03.
Poster presentation
NHRI Research Day, Miaoli, Taiwan
Topic: Defective RNF43 Leads to Enhanced B-RAF/MEK Signaling and Creates a Combinatory Therapeutic Target in Cancer Cells
2024.03.
Poster presentation
NHRI Research Day, Miaoli, Taiwan
Topic: RNF43 Inactivation Enhances the B-RAF/MEK Signaling and Creates a Combinatory Therapeutic Target in Cancer Cells
❖ Public presentation
2024. 03
NHRI Research Findings Press Conference
Ministry of Health and Welfare (MOHW), Taiwan
Topic: The Dual Precise Strategy of Targeting the "Achilles' Heel" in Pancreatic Cancer by NHRI and KMU
2024Recipient
Tzu-Yu Lai, M.D. (賴姿妤)
Lecturer, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan (2018/2~)
Lecturer, Ministry of Education, Taiwan (2018/7~)
2024Recipient
Tzu-Yu Lai, M.D. (賴姿妤)
Lecturer, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan (2018/2~)
Lecturer, Ministry of Education, Taiwan (2018/7~)
❖ Education:
Doctor of Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan (2004/9~2011/6)
PhD candidate, Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan (2022/6~)
❖ Training and Experiences:
Resident, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan (2012/8~2012/12)
Resident, Department of Heavy Particles & Radiation Oncology, Taipei Veterans General Hospital, Taipei, Taiwan (2013/1~2017/10)
Research Fellow, Department of Heavy Particles & Radiation Oncology, Taipei Veterans General Hospital, Taipei, Taiwan (2017/11~2018/7)
❖ Award
Best Paper Award, Taiwan Breast Cancer Foundation, 2023
Best Paper Award in Cancer Medicine, Journal of the Chinese Medical Association, 2017
❖ Publications:
Original Article
1. Tzu-Yu Lai, Yu-Wen Hu, Ti-Hao Wang, Jui-Pin Chen, Cheng-Ying Shiau, Pin-I Huang, I-Chun Lai, Ling-Ming Tseng, Nicole Huang, Chia-Jen Liu. Association of Radiation
Dose to Cardiac Substructures with Major Ischaemic Events Following Breast Cancer Radiotherapy. European Heart Journal, 2023 Dec 1;44(45):4796-4807. (SCI, IF: 39.3;
R/C: 2/143)
2. Yuan-Hung Wu, Yu-Mei Kang, Yu-Wen Hu, Keng-Li Lan, Sang-Hue Yen, Tzu-Yu Lai, Tien-Li Lan, Yuh-Min Chen, Chao-Hua Chiu, Yung-Hung Luo, Heng-Sheng Chao,
Chi-Lu Chiang, Tsu-Hui Shiao, Chao-Neng Yang, Wen-Hu Hsu, Yu-Chung Wu, Han-Shui Hsu, Jung-Jyh Hung, Chien-Sheng Huang, Po-Kuei Hsu, Yi-Wei Chen. Old age
and EGFR mutation status in inoperable early-stage non-small cell lung cancer patients receiving stereotactic ablative radiotherapy: A single institute experience of 71
patients in Taiwan. Thoracic Cancer, 2023 Mar;14(7):654-661. doi: 10.1111/1759-7714.14786; (SCI, IF: 2.9; R/C: 163/241)
3. Chen-Hua Lin, Tzu-Yu Lai, Yu-Jen Chen, Shun-Ku Lin. Social distance towards schizophrenia in health professionals. Asia Pac Psychiatry, 2022 Sep; 14(3):e12506. doi:
10.1111/appy.12506. (SCI, IF: 3.5; R/C: 60/144)
4. Tzu-Yu Lai, Chiu-Mei Yeh, Yu-Wen Hu, Chia-Jen Liu. Hospital volume and physician volume in association with survival in patients with nasopharyngeal cancer after
radiation therapy. Radiotherapy and Oncology, 2020 Oct;151:190-191. (SCI, IF: 6.2; R/C: 15/133)
5. Tzu-Yu Lai, Ti-Hao Wang, Chia-Jen Liu, Tze-Fan Chao, Tzeng-Ji Chen, Yu-Wen Hu. Risk factors for osteonecrosis of the jaw in oral cancer patients after surgery and
eventual adjuvant treatment: The potential role of chemotherapy. Radiotherapy and Oncology. 2017 Jun;123(3):406-411. (SCI, IF: 4.328; R/C: 13/126)
6. Tzu-Yu Lai, Yu-Wen Hu, Yu-Ming Liu, Yi-Wei Chen, Cheng-Ying Shiau, Pen-Yuan Chu, Shyh-Kuan Tai, Wen-Liang Lo, Cheng-Hsien Wu, Ling-Wei Wang. The pattern
of failure and predictors of locoregional control in lateralized buccogingival cancer after postoperative radiation therapy. Journal of the Chinese Medical Association,
2017. Sep;80(9):569-574. (SCI, IF: 1.252. R/C: 82/154)
7. Yuan-Hung Wu, Wan-Chin Yang, Yu-Wen Hu, Chuen-Mei Hsieh, Kai-Lin Yang, I-Chun Lai, Chen-Xiong Hsu, Ti-Hao Wang, Tzu-Yu Lai, Kuan-Ting Chen, Yu-Mei Kang,
Yu-Ming Liu. Definitive Radiotherapy for Older Patients with Prostate Cancer: Experience of a Medical Center in Taiwan. Scientific Report, 2017 Oct 24;7(1):13880.
(SCI, IF: 4.259, R/C: 10/64)
8. Tzu-Yu Lai, Tze-Fan Chao, Tzeng-Ji Chen, Yu-Ming Liu, Yu-Wen Hu. The risk of cancer in patients with keloid and the association with radiotherapy. Therapeutic
Radiology and Oncology 2017; 24(4): 279-291 (non-SCI)
9. Yuan-Hung Wu, Yu-Wen Hu, Chuen-Mei Hsieh, Kai-Lin Yang, I-Chun Lai, Chen-Xiong Hsu, Ti-Hao Wang, Tzu-Yu Lai, Kuan-Ting Chen, Cheng-Ying Shiau, Ling-Wei
Wang, Yu- Ming Liu. Preliminary Outcome of Definitive Radical Radiotherapy for Adenocarcinoma of Prostate in an Era of Intensity-Modulated Radiotherapy:
Experience of 564 Patients in a Medical Center in Taiwan. Therapeutic Radiology and Oncology 21:3 2014.09 155-174 (non-SCI)
Letter
1. Tzu-Yu Lai, Yu-Wen Hu. Neoadjuvant Therapy in Resectable Pancreatic Cancer: Immortal Time Bias and Its Correction. Journal of Clinical Oncology, 2017 May; 35(14),
1623. (SCI, IF: 24.008, R/C: 5/217)
Poster
1. Risk factors for osteonecrosis of jaw in oral cancer patients: a nation-wide population-based study (2015 ASTRO poster); International Journal of Radiation Oncology,
Biology, Physics. Volume 93, Issue 3, Supplement, November 2015, Pages E343
2. Tzu-Yu Lai et al. The pattern of failure and predictors of locoregional control in lateralized oral cancer after postoperative radiation therapy. 20th TJCC poster, 2015
3. Tzu-Yu Lai et al. Major Ischemic Heart Events for Patients with Breast Cancer After Radiotherapy: Exploring the Optimum Dose-volume Parameter of Cardiac Substructures
for Risk Prediction. 28th TJCC poster, 2023
2024Recipient
Yung-Yeh Su,M.D.,Ph.D.(蘇勇曄)
Assistant Investigator and Attending Physician, National Institute of Cancer Research, National Health Research Institute, Tainan, Taiwan
2024Recipient
Yung-Yeh Su,M.D.,Ph.D.(蘇勇曄)
Assistant Investigator and Attending Physician, National Institute of Cancer Research, National Health Research Institute, Tainan, Taiwan
❖ Education
Sep. 2005 – May 2012 M.D., School of Medicine, Kaohsiung Medical University
Aug. 2018 – Dec. 2023 Ph.D., Institute of Clinical Medicine, National Cheng Kung University
❖ Current position
Jan. 2023 – present Assistant Investigator and Attending Physician, National Institute of Cancer Research,
National Health Research Institute, Tainan, Taiwan
Oct. 2022 – present Adjunct Attending physician, Department of Internal Medicine, Kaohsiung Medical University Hospital
and Center for Cancer Research, Kaohsiung Medical University,Kaohsiung, Taiwan
Sep. 2019 – present Adjunct Attending physician, Department of Oncology, National Cheng Kung University Hospital,
Tainan, Taiwan
❖ Professional & Experiences
Apr. 2020 – Dec. 2022 Attending physician, National Institute of Cancer Research, National Health Research Institute, Tainan, Taiwan
Aug. 2017 – Aug. 2019 Fellow, Division of Medical Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
Sep. 2015 – Jul. 2017 Resident, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
Aug. 2014 – Jul. 2015 Resident, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
❖ Honors & Awards
2024 Young Investigator Award, Japanese Society of Medical Oncology (JSMO)
2023 Best Oral Presentation Award and Travel Award, Asian Oncology Society (AOS)
2023 Best Poster Award (特優), Taiwan Joint Cancer Conference (TJCC)
2023 Young Investigator Award, Japanese Society of Medical Oncology (JSMO)
2023 Best Presentation and Discussion Award, JSMO - Rising Stars in Asia Workshop
2022 Best Poster Award 2nd Prize (優等), Taiwan Joint Cancer Conference (TJCC)
2022 Young Investigator Award, Japanese Society of Medical Oncology (JSMO)
2023Recipient
Rodney Cheng-En Hsieh, M.D., Ph.D. (謝承恩)
Department of Radiation Oncology, Chang Gung Memorial Hospital at Linkou
2023Recipient
Rodney Cheng-En Hsieh, M.D., Ph.D. (謝承恩)
Department of Radiation Oncology, Chang Gung Memorial Hospital at Linkou
❖ Current Position
Assistant Professor, Department of Radiation Oncology, Chang Gung Memorial Hospital at Linkou, Taiwan
❖ Education
Doctor of Philosophy, Cancer Biology and Immunology, MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston,
TX, USA
Doctor of Medicine, School of Medicine, Chang Gung University, Taoyuan, Taiwan
❖ Professional & Experiences
Assistant Professor, Radiation Oncology, Chang Gung Memorial Hospital at Linkou, Taiwan
Visiting scientist, Experimental Radiation Oncology, MD Anderson Cancer Center, TX, USA
Attending Physician, Radiation Oncology, Chang Gung Memorial Hospital at Linkou, Taiwan
Residency, Radiation Oncology, Chang Gung Memorial Hospital at Linkou, Taiwan
Residency, Internal Medicine, Taipei City Hospital, Taiwan
2023Recipient
Wen-Chi Yang,MD(楊文綺)
2023Recipient
Wen-Chi Yang,MD(楊文綺)
Current position:
January, 2023-present
Attending physician, Department of Radiation Oncology, National Taiwan University Cancer Center
Education:
September, 2005-June, 2012
M.D. Doctor of Medicine, Chang Gung University, Taoyuan, Taiwan
September, 2018-present
PhD program, Graduate Institute of Oncology, National Taiwan University College of Medicine
Training and Experiences:
July, 2011-June, 2012
Intern physician, Chang Gun Memorial Hospital, Linkou branch, Taoyuan, Taiwan
July, 2012-June, 2013
Post-Graduate Year resident physician, National Taiwan University Hospital, Taipei, Taiwan
July, 2013-June, 2017
Resident physician, Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital
July, 2017-July, 2019
Attending physician, Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Yunlin branch
August, 2019-January, 2023
Attending physician, Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital
2022Recipient
Po-Ming Chow,M.D., Ph.D.(周博敏)
Department of Urology, National Taiwan University Hospital
2022Recipient
Po-Ming Chow,M.D., Ph.D.(周博敏)
Department of Urology, National Taiwan University Hospital
❖ Current Position
Attending Physician, Department of Urology, National Taiwan University Hospital
Assistant Professor, College of Medicine, National Taiwan University
❖ Education
Bachelor of Medicine, School of Medicine, College of Medicine, National Taiwan University
Ph.D., Graduate Institute of Toxicology, College of Medicine, National Taiwan University
❖ Professional & Experiences
Resident, Department of Urology, National Taiwan University Hospital
Fellow, Department of Urology, National Taiwan University Hospital
Trainee, European Urology Residents Education Programme
Robotic Surgery, Clinique Saint-Augustin, Bordeaux, France
Robotic Surgery, Fundació Puigvert, Barcelona, Spain
Laparoscopic and reconstructive surgery, La Paz University Hospital , Madrid, Spain
❖ Awards and Honours
Delegate to Japanese Urological Association annual meeting, (2015)
Delegate to Urological Association of Asia Youth Section Fellowship (2016)
Delegate to European Association of Urology academic exchange programme (2019)
Best Journal Article Award (Taiwan Urological Association, 2020)
Best Journal Article Award (Taiwan Urological Association, 2021)
2021Recipient
Si-Han Wu, Assistant Professor (吳思翰)
Graduate Institute of Nanomedicine and Medical Engineering, Taipei Medical University
2021Recipient
Si-Han Wu, Assistant Professor (吳思翰)
Graduate Institute of Nanomedicine and Medical Engineering, Taipei Medical University
❖ Education & Training Background: ⎢ View full profile ⎢
2007-2013 Chemistry, Doctor of Science, National Taiwan University, Taipei, Taiwan
2005-2007 Chemistry, Master of Science, National Taiwan University, Taipei, Taiwan
2001-2005 Chemistry, Bachelor of Science, Fu Jen Catholic University, Hsinchuang, Taiwan
❖ Emplyment History:
2015-present Assistant Professor, Graduate Institute of Nanomedicine and Medical Engineering, Taipei Medical University
2015/11-2016/06 Visiting Scholar, Mork Family Department of Chemical Engineering and Materials Science, University of Southern
California
2015/01-2015/08 Postdoctoral Fellow, Research Center for Applied Sciences, Academia Sinica
2014/03-2014/12 Postdoctoral Fellow, Department of Chemistry, National Taiwan University, Taipei, Taiwan
2009/07-2009/11 Visiting Student Program, Department of Radiology, Washington University School of Medicine in St. Louis.
2020Recipient
Chia-Chi Hsu, Ph.D. (許家齊)
❖ Education: ⎢ View full profile ⎢
2009-2015 Ph.D., Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University
2007-2009 M.S., Institute of Biochemistry and Biotechnology, College of Medicine, Chung Shan Medical University
❖ Interest and Specialty：
1. Basic research
2. Translational cancer research
3. Mechanism of drug resistance in cancer treatment
4. Cancer metabolism
❖ Academia Appointments：
Post-doctoral fellow-
2018- Graduate Institute of Oncology, National Taiwan University
2017-2018 National Taiwan University Cancer Center
2016-2017 Department of Oncology, National Taiwan University Hospital
2020Recipient
Jie Lee, M.D., Ph.D. (李杰)
Department of Radiation Oncology, MacKay Memorial Hospital
2020Recipient
Jie Lee, M.D., Ph.D. (李杰)
Department of Radiation Oncology, MacKay Memorial Hospital
❖ Education: ⎢ View full profile ⎢
2002-2009 M.D. Department of Medicine, Chung Shan Medical University
2016-2019 Ph.D. Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University
❖ Employment Record:
2016- : Attending Physician, Department of Radiation Oncology, MacKay Memorial Hospital
2020- : Assistant Professor, Department of Medicine, MacKay Medical College
❖ Professional Affiliations:
1. The Taiwanese Society for Therapeutic Radiology and Oncology (TASTRO)
2. American Society for Therapeutic Radiology and Oncology (ASTRO)
3. European Society for Radiotherapy and Oncology (ESTRO)
4. Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD)
